|Bid||5,370.05 x 0|
|Ask||5,371.95 x 0|
|Day's Range||5,370.05 - 5,417.80|
|52 Week Range||4,708.00 - 6,408.00|
|PE Ratio (TTM)||34.40|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you're concerned about a forthcoming market correction, GlaxoSmithKline, AT&T, and Procter & Gamble may be worth buying right now.
Sir, Joining in the discussion about GlaxoSmithKline's new plans, I find chief executive Emma Walmsley's strategic thinking on research and development questionable. I suggest it shows the terrible consequences ...
Barely four months into her tenure as chief executive of GlaxoSmithKline, Emma Walmsley is showing her determination to focus the pharmaceutical company's research and development efforts. Having said ...